ID: ALA166171

Max Phase: Preclinical

Molecular Formula: C50H57NO15

Molecular Weight: 912.00

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccc(C(=O)c5ccccc5)cc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C

Standard InChI:  InChI=1S/C50H57NO15/c1-26-32(63-44(59)39(56)36(51-45(60)66-46(3,4)5)28-19-21-30(22-20-28)37(54)29-15-11-9-12-16-29)24-50(61)42(64-43(58)31-17-13-10-14-18-31)40-48(8,41(57)38(55)35(26)47(50,6)7)33(53)23-34-49(40,25-62-34)65-27(2)52/h9-22,32-34,36,38-40,42,53,55-56,61H,23-25H2,1-8H3,(H,51,60)/t32-,33-,34+,36-,38+,39+,40-,42-,48+,49-,50+/m0/s1

Standard InChI Key:  OMQAQZGDRCRRBT-UPTBTMBVSA-N

Associated Targets(non-human)

Tubulin alpha chain 497 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

P388 20296 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 912.00Molecular Weight (Monoisotopic): 911.3728AlogP: 4.49#Rotatable Bonds: 10
Polar Surface Area: 241.52Molecular Species: NEUTRALHBA: 15HBD: 5
#RO5 Violations: 2HBA (Lipinski): 16HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.87CX Basic pKa: CX LogP: 4.38CX LogD: 4.38
Aromatic Rings: 3Heavy Atoms: 66QED Weighted: 0.08Np Likeness Score: 1.63

References

1. Bourzat J, Lavelle F, Commercon A.  (1995)  Synthesis and biological activity of Para-substituted 3-phenyl docetaxel analogs,  (8): [10.1016/0960-894X(95)00118-D]
2. Sivakumar PM, Naga Vignesh, Ramesh Kumar G, Doble M.  (2012)  Computational approaches to enhance activity of taxanes as antimitotic agent,  21  (9): [10.1007/s00044-011-9779-x]

Source